Harvard Study Finds N.C. Diabetes 'Epidemic' Costs Billions | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Harvard Study Finds N.C. Diabetes 'Epidemic' Costs Billions

May 30, 2014
by John DeGaspari
| Reprints
Broad-based solutions urged, including telemedicine and self-management programs

A new Harvard study says diabetes rates in North Carolina have nearly doubled in 20 years, Philanthropy North Carolina has reported.

That surge costs billions of dollars in medical spending and a less efficient workforce, according to the study from Harvard Law School. At its current pace, it says, diabetes is on track to cost the state's public and private sectors over $17 billion a year in medical expenses and lost productivity by 2025.

Diabetes is now the seventh-leading cause of death in the state, where the disease is far more prevalent than in the U.S. overall, the study says. And among African Americans and American Indians in the state, it is the fourth-leading and third-leading cause of death, respectively.

The study, “2014 New Carolina State Report: Providing Access to Healthy Solutions (PATHS)—The Diabetes Epidemic in North Carolina: Policies for Moving Forward” calls for “multipronged changes to the state's healthcare, nutrition and physical activity landscapes.

Among those recommendations are:

  • Expand telemedicine programs and access to durable medical equipment and insulin.
  • Increase access to diabetes prevention and self-management programs.
  • Promote “team-based, whole-person models” to deliver and finance diabetes care.

Other recommendations include improved behavioral health services for people with diabetes, increased economic and geographic access to healthy food, more opportunities for physical activities, and nutrition and cooking education, and expanded programs for early childhood, school food, nutrition and wellness.

The study was funded through a grant from the Bristol-Myers Squibb Foundation. Philanthropy North Carolina reported on the study in a joint project with NCPressRelease.com, with funding from Blue Cross and Blue Shield of North Carolina.


Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).